Nephrocare trading window closed from June 22 until Q1FY27 results

0 min read     Updated on 20 Jun 2026, 06:17 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Nephrocare Health Services Ltd has closed its trading window for designated persons effective June 22, 2026, due to unpublished price sensitive information including Q1FY27 results. The window will reopen 48 hours after the unaudited financial results for the quarter ended June 30, 2026 are declared, in compliance with SEBI regulations.

powered bylight_fuzz_icon
43410710

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services Ltd has closed its trading window for designated persons and their immediate relatives effective June 22, 2026, due to the existence of unpublished price sensitive information. The closure encompasses the financial results of the company for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.

The decision is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives. This measure ensures compliance with regulatory standards to prevent insider trading during the period of financial result finalization.

Key Dates and Details

Event Date
Trading Window Closure June 22, 2026
Quarter End June 30, 2026
Window Reopens 48 hours after Q1FY27 results declaration

The intimation regarding the closure has been made available on the company's official website. Kishore Kathri, the Company Secretary & Compliance Officer, signed the disclosure on June 19, 2026.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%+9.70%+4.80%+34.75%+46.38%+46.38%

How might the upcoming Q1FY27 results impact Nephrocare's stock performance once the trading window reopens?

What strategic initiatives or operational changes contributed to the unpublished price-sensitive information?

How will investors react to the financial results given the extended trading window closure?

Nephrocare Health Services
View Company Insights
View All News
like15
dislike

Investcorp confirms no encumbrance on Nephrocare shares in FY26

1 min read     Updated on 19 Jun 2026, 04:17 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Investcorp Private Equity Fund II declared that no encumbrance was created on the shares of Nephrocare Health Services Limited during FY26, other than those previously disclosed. The filing was submitted to BSE and NSE in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

powered bylight_fuzz_icon
42673517

*this image is generated using AI for illustrative purposes only.

Investcorp Private Equity Fund II has confirmed that no encumbrance was created on the shares of nephrocare health services during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, assures stakeholders that the shares remain free from new charges or liens, other than those already disclosed. This disclosure provides transparency regarding the financial standing of the promoter's holdings in Nephrocare Health Services Limited.

The confirmation was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Investcorp Private Equity Fund II, being a promoter of the Target Company, along with persons acting in concert, stated that no direct or indirect encumbrance has been created on the shares during the specified period. The filing was addressed to BSE Limited and the National Stock Exchange of India Limited to ensure the information is on public record.

Entity Role
Investcorp Private Equity Fund II Promoter
Nephrocare Health Services Limited Target Company

Copies of the declaration were sent to the Audit Committee and the Company Secretary and Compliance Officer of Nephrocare Health Services Limited for their internal records and necessary action. The company is formerly known as Nephrocare Health Services Private Limited.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%+9.70%+4.80%+34.75%+46.38%+46.38%

Does the absence of new encumbrances signal Investcorp's intention to maintain its current holding or prepare for a stake sale?

How might this clean financial position impact Nephrocare's ability to secure future funding or attract strategic partners?

What are the potential growth strategies for Nephrocare Health Services under Investcorp's continued promoter status?

Nephrocare Health Services
View Company Insights
View All News
like17
dislike

More News on Nephrocare Health Services

1 Year Returns:+46.38%